ArticleMedicine2018

Sustained clinical response after single course of rituximab as first-line monotherapy in adult-onset asthma and periocular xanthogranulomas syndrome associated with IgG4-related disease: A case report.

Giovanni Pomponio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.